BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2554014)

  • 1. [Malignant lymphoma which contained EBV DNA and lacked EBNA2 antibody].
    Shimakage M; Hirai K; Ikegami N; Matsubuchi T; Kawagoe H
    Rinsho Ketsueki; 1989 Jul; 30(7):1091-2. PubMed ID: 2554014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV) antibodies in children with non-Hodgkin's lymphomas.
    Roubalová K; Weinreb M; Roubal J; Kodet R; Koutecký J; Vonka V
    Acta Virol; 1988 Jul; 32(4):339-48. PubMed ID: 2903639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
    Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
    Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein Barr virus (EBV) carrying cells in blood of Hodgkin's disease (HD) and non-Hodgkin lymphoma (NHL) patients with high antibody titers against EBV capsid antigens (VCA).
    Lewin N; Aman P; Mellstedt H; Carenfelt C; Klein G; Klein E
    Anticancer Res; 1990; 10(5A):1213-6. PubMed ID: 2173472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo.
    Edson CM; Cohen LK; Henle W; Strominger JL
    J Immunol; 1983 Feb; 130(2):919-24. PubMed ID: 6294181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
    Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
    Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
    Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
    J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody against synthetic peptide derived from Epstein-Barr virus-determined nuclear antigen 1 (EBNA-1) in child non-Hodgkin's lymphoma.
    Sova P; Roubalová K; Weinreb M; Hamsíková E; Kodet R; Krchnák V; Roubal J
    Acta Virol; 1990 Apr; 34(2):132-8. PubMed ID: 1975974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of Epstein-Barr virus nucleic acid sequences in non-Hodgkin's lymphoma].
    Sauerbrei A; Wutzler P; Färber I; Wutke K; Brichacek B; Hirsch I
    Arch Geschwulstforsch; 1987; 57(6):445-52. PubMed ID: 2829788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach.
    Fukayama M; Hayashi Y; Iwasaki Y; Chong J; Ooba T; Takizawa T; Koike M; Mizutani S; Miyaki M; Hirai K
    Lab Invest; 1994 Jul; 71(1):73-81. PubMed ID: 8041121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of Epstein-Barr virus DNA in tonsillar tissues.
    Brichácek B; Suchánková A; Hirsch I; Síbl O; Rezácova D; Závadová H; Vonka V
    Acta Virol; 1981 Nov; 25(6):361-70. PubMed ID: 6120637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluctuation in Epstein-Barr virus-related antibody titers by age: response differences between the IgG antibodies to VCA and anti-EBNA antibodies].
    Kumagai E; Tanaka R; Kumagai T; Katsuki T; Sawada S
    Rinsho Byori; 1984 Jun; 32(6):666-70. PubMed ID: 6092744
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome.
    Jones JF; Williams M; Schooley RT; Robinson C; Glaser R
    Arch Intern Med; 1988 Sep; 148(9):1957-60. PubMed ID: 2843138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.